Overview

Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus

Status:
Unknown status

Trial end date:
2015-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the effectiveness of rituximab alone vs combination of rituximab and cyclophosphamide in the treatment of pemphigus not responding adequately to routine medications.

Phase:

Phase 3

Details

Lead Sponsor:

Uprety Shraddha

Collaborator:

Postgraduate Institute of Medical Education and Research

Treatments:

Cyclophosphamide
Rituximab